Tumor-derived exosomes carry PD-L1 and immunosuppressive miRNAs that systemically blunt immune activity, while immune cell-derived exosomes activate anti-tumor responses via MHC and co-stimulatory molecule delivery (51–55). This evidence concerns the gene HLA-C and neoplasm.